Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Healthtrust
Colorcon
Daiichi Sankyo
Accenture
Fuji
Argus Health
AstraZeneca
Johnson and Johnson

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BESIFLOXACIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Besifloxacin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00347932 A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. Completed Bausch & Lomb Incorporated Phase 3 Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.
NCT00348348 A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Completed Bausch & Lomb Incorporated Phase 3 This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.
NCT00407589 Systemic Pharmacokinetics of BOL-303224-A Completed Bausch & Lomb Incorporated Phase 1 This is a multi-center, open-label, single dose/multiple dose, pharmacokinetic study in participants with bacterial conjunctivitis. The purpose of this study is to determine the extent of systemic exposure to BOL-303224-A following single and multiple topical administration of BOL-303224-A in participants with suspected bacterial conjunctivitis.
NCT00622908 Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis Completed Bausch & Lomb Incorporated Phase 2 To evaluate the clinical and microbial efficacy of ISV-403 administered three times a day (TID) for 5 days compared to vehicle three times a day for 5 days in the treatment of bacterial conjunctivitis
NCT00824070 Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects Completed Bausch & Lomb Incorporated Phase 1 This study is being conducted to assess the concentration of besifloxacin, moxifloxacin, or gatifloxacin in aqueous humor samples collected following topical instillation of the associated formulation in subjects undergoing cataract surgery.
NCT00905762 Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation Completed Bausch & Lomb Incorporated Phase 1 The purpose of this study is to assess the concentration of besifloxacin compared to gatifloxacin and moxifloxacin in human conjunctival tissue, following a single drop of the drug instilled topically into the study eye. Conjunctival biopsies will be performed at specified time points, followed by the use of loteprednol etabonate/tobramycin ophthalmic suspension four times a day for 5 days.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Besifloxacin Hydrochloride

Condition Name

Condition Name for Besifloxacin Hydrochloride
Intervention Trials
Bacterial Conjunctivitis 5
Acute Bacterial Conjunctivitis 2
Cataract Extraction 2
Healthy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Besifloxacin Hydrochloride
Intervention Trials
Conjunctivitis, Bacterial 8
Conjunctivitis 8
Cataract 4
Pseudophakia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Besifloxacin Hydrochloride

Trials by Country

Trials by Country for Besifloxacin Hydrochloride
Location Trials
United States 14
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Besifloxacin Hydrochloride
Location Trials
New York 5
New Jersey 2
Tennessee 1
Pennsylvania 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Besifloxacin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Besifloxacin Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Besifloxacin Hydrochloride
Clinical Trial Phase Trials
Completed 10
Terminated 3
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Besifloxacin Hydrochloride

Sponsor Name

Sponsor Name for Besifloxacin Hydrochloride
Sponsor Trials
Bausch & Lomb Incorporated 12
Rutgers, The State University of New Jersey 1
Bucci Laser Vision Institute 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Besifloxacin Hydrochloride
Sponsor Trials
Industry 13
Other 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Johnson and Johnson
US Army
Mallinckrodt
Baxter
Covington
Cipla
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.